Li Huang
Chengdu, 610072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Shi Pi Shu Gan Formula Prevents and Treats Sequelae of Pelvic Inflammatory Disease by Regulating PKA-CREB-Yap1 Signaling through the mtDNA/cGAS/STING Network.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: January 21, 2026
Discovery of notoprenylate F from Notopterygium incisum (Qianghuo) as a PPARγ agonist with potent anti-inflammatory activity through HTS2.
Journal: Marine life science & technology
Published: August 20, 2025
Yi-Qi-Qing-Shi-Hua-Yu method improves uterine inflammation in rats with sequelae of pelvic inflammatory disease through the TLR4/NF-κB signaling pathway and regulates intestinal flora.
Journal: Tissue & cell
Published: November 07, 2024
Modified Hongteng Baijiang decoction enema improves sequelae of pelvic inflammatory disease by regulating the LIF/JAK2/STAT3 pathway and gut microbiota.
Journal: Immunity, inflammation and disease
Published: September 10, 2023
Efficacy and security of oral Chinese patent medicine combined with antibiotics in the treatment of pelvic inflammatory disease: a Bayesian network meta-analysis.
Journal: BMC complementary medicine and therapies
Published: August 26, 2023
Shipi Shugan Decoction Protected against Sequela of Pelvic Inflammatory Disease via Inhibiting SIRT1/NLRP3 Signaling Pathway in Pelvic Inflammatory Disease Rats.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: December 19, 2021
Fuke Qianjin Combined with Antibiotic Therapy for Pelvic Inflammatory Disease: A Systematic Review and Meta-Analysis.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: February 26, 2020
Type B Chloramphenicol Acetyltransferases Are Responsible for Chloramphenicol Resistance in Riemerella anatipestifer, China.
Journal: Frontiers in microbiology
Published: October 06, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026